Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis

Risk factors and outcome associated with the acquisition of linezolid-resistant Enterococcus faecalis

Objectives: Linezolid is a synthetic oxazolidinone antibiotic frequently used to treat vancomycin-resistant enterococcal infections. Vancomycin-susceptible Enterococcus faecalis can develop resistance to linezolid in environments with excessive linezolid use. The aim of this study was to define risk...

Full description

Bibliographic Details
Main Authors: Eduardo Rodríguez-Noriega, Natalia Hernández-Morfin, Elvira Garza-Gonzalez, Paola Bocanegra-Ibarias, Samantha Flores-Treviño, Sergio Esparza-Ahumada, Esteban González-Díaz, Héctor Raúl Pérez-Gómez, Christian Mendoza-Mujica, Gerardo León-Garnica, Rayo Morfín-Otero
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Linezolid-resistant
Enterococcus faecalis
Risk factors
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716520300114

Internet

http://www.sciencedirect.com/science/article/pii/S2213716520300114

Similar Items